Zhao, Z., Yang, C., Chen, S., Yu, H., Lin, Y., Lin, Y., . . . Long, H. (2021). Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer. Taylor & Francis Group.
Chicago Style (17th ed.) CitationZhao, Ze-Rui, et al. Phase 2 Trial of Neoadjuvant Toripalimab with Chemotherapy for Resectable Stage III Non-small-cell Lung Cancer. Taylor & Francis Group, 2021.
MLA (8th ed.) CitationZhao, Ze-Rui, et al. Phase 2 Trial of Neoadjuvant Toripalimab with Chemotherapy for Resectable Stage III Non-small-cell Lung Cancer. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.